Skip to main content
OpenTrials
Completed

NCT Number: NCT04231656

Pulse CONtour and BIoimpedance for Measurements of Stroke Volume During Changes in CARdiac Preload

Fluid therapy guided by stroke volume response to repeated fluid challenges is used for hemodynamic optimization during general anesthesia. Two types of devices that measure stroke volume non-invasively are primarily available for intermediate-risk surgery under general anesthesia. They are based on two different techniques, (1) pulse contour analysis, and (2) transthoracic bioimpedance. They have never been compared with each other. Therefore, it is not known (1) whether they are interchangeable for the measurement of stroke volume changes (usually assessed as the "concordance" of two techniques), and (2) whether one is better than the other.

The aim is to study the concordance of these two non-invasive hemodynamic devices. it will use both of them in patients undergoing intermediate risk surgery. They will be tested during modifications of cardiac preload induced by Trendelenburg and anti-Trendelenburg positioning, as well as during intraoperative fluid challenges, vasopressor boluses and alveolar recruitment maneuvers.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hemodynamic, Monitoring Anesthesia Blood Pressure

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hôpital Roger Salengro, CHU Lille

Lille, 59037, France

About this study

The main objective is to assess the concordance of two non-invasive devices using the technology described above : the Clearsight (Edwards Lifesciences, pulse contour analysis), and the Niccomo (Medis, bioimpedance). Both will be used in each patient included in the study. They will be tested during modifications of cardiac preload induced by sequences of position changes (see below) including Trendelenburg and anti-Trendelenburg positioning, performed systematically before and after the procedure, as well as during fluid challenges, vasopressor boluses and alveolar recruitment maneuvers (performed during the procedure according to the needs of the anesthesiologist in charge of the patient). Both monitors will also be compared with an invasive monitor of stroke volume (Vigileo/Flotrac, Edwards Lifesciences), and the respiratory pulse pressure variation will also be measured during the sequences of position changes and will be used as a gold standard for fluid responsiveness.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Eligible and suitable for intermediate risk surgery, validated by anaesthesia consultation.

There is no definitive definition of intermediate risk. By reference to the literature, surgeries longer than 2 hours (excluding "low risk") and less than 3% postoperative mortality (excluding high-risk surgery). It includes the majority of non-serious visceral (abdominal and gynecological) surgery, plastic or cervical-facial surgery for neoplastic removal or long-term reconstruction, or long-term spinal surgery or neurosurgery of the base of the skull.

  • For which the anesthesiologist in charge has planned an invasive monitoring (radial catheter) of arterial blood pressure.

Exclusion criteria

  • Urgent surgery
  • Intracranial hypertension
  • Orthostatic hypotension
  • Extreme anthropometry: weight >150 kg and 30 kg, size 120 cm and >230 cm
  • Related to NICCOMO monitoring:
  • Rhythmic anomaly: Atrial fibrillation, tachycardia with heart rate >200 beats per minute.
  • Aortic disease: Severe sclerosis
  • Valve dysfunction: severe aortic regurgitation,
  • Patient with aortic prosthesis or pacemaker using impedance detection.
  • Occurrence of tachycardia > 200 bpm, occurrence of hypertension with mean arterial pressure >130 mm Hg
  • Simultaneous use of electrical cauterization systems during surgical procedures
  • Septic shock
  • Related to CLEARSIGHT monitoring
  • Patient with prior distal perfusion disorders
  • Lower extremity obliterans arteritis stage IV

Treatment and study plan

CLEARSIGHT and NICCOMO measurements in sequence A

Device

Starting from 0° position, shift to position +20°, then tilt to -20°, and finally back to the 0° position.

Other names: CLEARSIGHT and NICCOMO devices (both used during each sequence)

CLEARSIGHT and NICCOMO measurements in sequence B

Device

Starting from 0° position, shift to position -20°, then tilt to +20°, and finally back to the 0° position and collect the last group of figures.

Other names: CLEARSIGHT and NICCOMO devices (both used during each sequence)

Primary outcomes

  1. concordance of stroke volume changes measured with each monitor during the standardized maneuvers of sequences A and B (total: 6 observations per individual).

    Time frame: during each changes of positioning (i.e., for 1-2 minutes in each condition, for a total of 10-15 minutes following initial measurements in basal conditions), during sequences A and B

    4-quadrant plot

Secondary outcomes

  1. Fluid responsiveness defined by areas under the Receiver Operating Characteristic curve (sensitivity and specificity)

    Time frame: during each changes of positioning (i.e., for 1-2 minutes in each condition, for a total of 10-15 minutes following initial measurements in basal conditions), during sequences A and B

    Comparison of areas under the Receiver Operating Characteristic curve (sensitivity and specificity). Each maneuver will be classified as "responder" or "nonresponder" according to the value of Pulse Pressure Variation (PPV) recorded before the maneuver and to the changes in PPV during the maneuver (as previously published)

  2. concordance of stroke volume changes measured with each monitor during the standardized maneuvers mimicking preload decrease.

    Time frame: during each changes of positioning where cardiac preload is supposed to decrease (i.e., for 1-2 minutes in one out of two condition, for a total of 10-15 minutes following initial measurements in basal conditions), during sequences A and B

    4-quadrant plot

  3. concordance of stroke volume changes measured with each monitor during the standardized maneuver mimicking preload increase.

    Time frame: during each changes of positioning where cardiac preload is supposed to increase (i.e., for 1-2 minutes in one out of two condition, for a total of 10-15 minutes following initial measurements in basal conditions), during sequences A and B

    4-quadrant plot

  4. concordance of stroke volume changes measured with each monitor during the surgical procedure (fluid challenges, vasopressor boluses, alveolar recruitment maneuver).

    Time frame: throughout surgery (mean length expected between 3 and 5 hours). Measurements performed during sequences of 5-20 minutes that can occur several times during surgery

    4-quadrant plot

  5. interchangeability of stroke volume measurements with each monitor during sequences A and B

    Time frame: before and after each changes of positioning (i.e., for 1-2 minutes in each condition, for a total of 10-15 minutes following initial measurements in basal conditions), during sequences A and B

    Bland and Altman plot for repeated measures

  6. interchangeability of stroke volume measured with each monitor during the surgical procedure (fluid challenges, vasopressor boluses, alveolar recruitment maneuver).

    Time frame: throughout surgery (mean length expected between 3 and 5 hours). Measurements performed before and after sequences of 5-20 minutes that can occur several times during surgery

    Bland and Altman plot for repeated measures

  7. concordance of stroke volume changes measured with each monitor with that measured by a Vigileo/Flotrac monitor during the standardized maneuvers of sequences A and B (total: 6 observations per individual).

    Time frame: during each changes of positioning (i.e., for 1-2 minutes in each condition, for a total of 10-15 minutes following initial measurements in basal conditions), during sequences A and B

    4-quadrant plot

Sponsors and collaborators

Lead sponsor

University Hospital, Lille

Other

Registry information

Official study title

Stoke Volume Measurements During Changes in Cardiac Preload: Are Pulse Contour Analysis (CLEARSIGHT) and Transthoracic Bioelectrical Impedance (NICCOMO) Equivalent?

Acronym: ConBi-Car

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
Jan 18, 2020
Registry last updated
Apr 21, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.